Advertisement

Clinical and Therapeutic Aspects of Alcoholic Liver Disease

  • C. L. Mendenhall
  • VA Cooperative Study on Alcoholic Hepatitis

Abstract

The socioeconomic health impact of alcoholism is enormous. In the United States in 1975, $ 12.74 billion was spent for health and medical expenses associated with alcoholism (Berry et al. 1977). The total number of deaths directly related to alcoholism in 1977 ranged between 18,066 and 34,724 (National Institute on Alcohol Abuse and Alcoholism 1978), 85% of these being associated with alcoholic liver disease. Indeed, death from cirrhosis ranks fourth among causes of death in the United States (US Bureau of Census 1975).

Keywords

Alcoholic Liver Disease Alcoholic Hepatitis Cooperative Study Group Alcoholic Fatty Liver Chronic Ethanol Administration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baker H, Frank O, Zetterman RK et al. (1975) Inability of chronic alcoholics with liver disease to use food as a source of folates, thiamin and vitamin B6. Am J Clin Nutr 28: 1377–1380PubMedGoogle Scholar
  2. Baker H, Frank O, Zieffer H et al. (1964) Effect of hepatic disease on liver B-complex vitamin titers. Am J Clin Nutr 14: 1–6PubMedGoogle Scholar
  3. Beckett AG, Livingstone AV, Hill KR (1962) Acute alcoholic hepatitis without jaundice. Br Med J 2: 580 - 582PubMedGoogle Scholar
  4. Bernstein J, Videla L, Israel Y (1973) Metabolic alterations produced in the liver by chronic ethanol administration. Changes related to energetic parameters of the cell. Biochem J 134: 515–521PubMedGoogle Scholar
  5. Berry RE, Boland JP, Smart CN et al. (1977) The economic costs of alcohol abuse and alcoholism — 1975. National Institute on Alcohol Abuse and Alcoholism, BethesdaGoogle Scholar
  6. Blackburn GL, Bistrian BR, Maini BS et al. (1977) Nutritional and metabolic assessment of the hospitalized patient. J Parent Enter Nutr 1: 11 - 22Google Scholar
  7. Blizter BL, Mutchnick MG, Joshi PH et al. (1977) Adrenocorticosteroid therapy in alcoholic hepatitis: a prospective double-blind randomized study. Dig Dis Sci 22: 477–484Google Scholar
  8. Brown JP, Davidson GE, Scott JM et al. (1973) Effect of diphenylhydantoin and ethanol feeding on the synthesis of rat liver folates from exogenous pteroylglutamate (3H). Biochem Pharmacol 22: 3287–3289PubMedGoogle Scholar
  9. Brunt PW, Kew MC, Scheuer PJ et al. (1974) Studies in alcoholic liver disease in Britain. Gut 15: 52–58PubMedGoogle Scholar
  10. Busch LA (1971) Human listeriosis in the United States. J Infec Dis 123: 328–331Google Scholar
  11. Campra JL, Hamlin EM, Kirshbaum RJ et al. (1973) Prednisone therapy of acute alcoholic hepatitis: report of a controlled trial. Ann Intern Med 79: 625–631PubMedGoogle Scholar
  12. Cherrick GR, Baker H, Frank O et al. (1965) Observations on hepatic avidity for folate in Laennec’s cirrhosis. J Lab Clin Med 66: 446–451PubMedGoogle Scholar
  13. Cherubin CE, Marr JS, Sierra MF et al. (1981) Listeria and gram-negative bacillary meningitis in New York City, 1972–1979. Am J Med 71: 199–209PubMedGoogle Scholar
  14. Cohen JA, Kaplan MM (1979) The SGOT/SGPT ratio: an indicator of alcoholic liver disease. Dig Dis Sci 24: 835–838PubMedGoogle Scholar
  15. Conn H, Fessel J (1971) Spontaneous bacterial peritonitis and cirrhosis: variations on a theme. Medicine 50: 161–197PubMedGoogle Scholar
  16. Copenhagen Study Group for Liver Diseases (1969) Effect of prednisone on the survival of patientswith cirrhosis of the liver. Lancet 1: 119–122Google Scholar
  17. Davis NC, Whipple GH (1919) The influence of fasting and various diets on the liver injury effected by chloroform anesthesia. Arch Intern Med 23: 612–635Google Scholar
  18. Depew W, Boyer T, Omata M et al. (1980) Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy. Gastroenterology 78: 524–529PubMedGoogle Scholar
  19. Digelman RF, Peterkofsky B (1972) Inhibition of collagen secretion from bone and cultured fibroblasts by microtubular disruptive drugs. Proc Natl Acad Sci USA 69: 89–896Google Scholar
  20. Edmondson HA, Peters RL, Reynolds TB et al. (1963) Sclerosing hyaline necrosis of the liver in the chronic alcoholic: a recognizable clinical syndrome. Ann Intern Med 59: 646–673PubMedGoogle Scholar
  21. Ehrlich HR, Bornstein P (1972) Microtubules in transcellular movement of procollagen. Nature 238: 257–260Google Scholar
  22. Erenoglu E, Edreira JG, Patek AJ (1964) Observations on patients with Laennec’s cirrhosis receiving alcohol while on controlled diets. Ann Intern Med 60: 814–823PubMedGoogle Scholar
  23. Feingold AO (1976) Association of tuberculosis and alcoholism. South Med J 69: 1336–1337PubMedGoogle Scholar
  24. French SW, Sim JS, Franks KE et al. (1977) Alcoholic hepatitis. In: Fisher MM, Rankin JG (eds) Alcohol and the liver. Plenum, New York, pp 261–288 (Hepatology research and clinical issues, vol 3 )Google Scholar
  25. Gabuzda G, Davidson CS (1962) Tryptophan and nicotinic acid metabolism in patients with cirrhosis of the liver. Am J Clin Nutr 11: 502–508PubMedGoogle Scholar
  26. Galambos JT (1972) Alcoholic hepatitis: its therapy and prognosis. In: Popper H, Schaffner F (eds) Progress in liver disease. Grune and Stratton, New York, pp 567–588Google Scholar
  27. Galambos JT, Hersh T, Fulenwider JT et al. (1979) Hyperalimentation in alcoholic hepatitis. Am J Gastroenterol 72: 535–541PubMedGoogle Scholar
  28. Goldschmidt S, Vars HM, Ravdin IS (1939) The influence of foodstuffs upon the susceptibility of the liver to injury by chloroform and the probable mechanism of their action. J Clin Invest 18: 277–289PubMedGoogle Scholar
  29. Gorwitz K, Bahn A, Warthen FJ et al. (1970) Some epidemiological data on alcoholism in Maryland. Q J Stud Alcohol 31: 423–443PubMedGoogle Scholar
  30. Green JR (1965) Subclinical acute liver disease of the alcoholic. Aust Ann Med 14: 111–124PubMedGoogle Scholar
  31. Halsted CH, Tamura T (1979) Folate deficiency in liver disease. In: Davidson CS (ed) Problems in liver diseases. Stratton, New York, pp 91–100Google Scholar
  32. Halsted CH, Griggs RC, Harris JW (1967) The effect of alcohol on the absorption of folic acid (H3-PGA) evaluation by plasma levels and urine excretion. J Lab Clin Med 69: 116–131PubMedGoogle Scholar
  33. Halsted CH, Robles EA, Mezey E (1971) Decreased jejunal uptake of labeled folic acid (3H-PGA) in alcoholic patients: roles of alcohol and nutrition. N Engl J Med 285: 701–706PubMedGoogle Scholar
  34. Hardison WG, Lee FI (1966) Prognosis in acute liver disease of the alcoholic patient. N Engl J Med 275: 61–66PubMedGoogle Scholar
  35. Harinasuta U, Chomet B, Ishak K et al. (1967) Steatonecrosis - Mallory body type. Medicine 46: 141–162PubMedGoogle Scholar
  36. Helman RA, Temko MH, Nye SW et al. (1971) Alcoholic hepatitis: natural history and evaluation of prednisolone therapy. Ann Intern Med 74: 311–321PubMedGoogle Scholar
  37. Hiñes JD (1975) Hematologic abnormalities involving vitamin B6 and folate metabolism in alcoholic subjects. Ann NY Acad Sci 252: 316–327PubMedGoogle Scholar
  38. Home DW, Briggs WT, Wagner C (1979) Studies on the transport mechanism of 5-methyltetra- hydrofolic acid in freshly isolated hepatocytes: effect of ethanol. Arch Biochem Biophys 196: 557–565Google Scholar
  39. Howard LC, Wagner C, Schenker S (1974) Malabsorption of thiamin in folate deficient rats. J Nutr 104: 1024–1032PubMedGoogle Scholar
  40. Israel Y, Videla L, MacDonald A et al. (1973) Metabolic alterations produced in the liver by chronic ethanol administration. Comparison between the effects produced by ethanol and by thyroid hormones. Biochem J 134: 523–529PubMedGoogle Scholar
  41. Israel Y, Videla L, Bernstein J (1975) Liver hypermetabolic state after chronic ethanol consumption: hormonal interrelationships and pathogenic implications. Fed Proc 34: 2052–2059PubMedGoogle Scholar
  42. Jabbari M, Leevy CM (1967) Protein anabolism and fatty liver of the alcoholic. Medicine 46: 131–139PubMedGoogle Scholar
  43. Jacobs RM, Sorrell MF (1981) The role of nutrition in the pathogenesis of alcoholic liver disease. Semin Liver Dis 1: 224–253Google Scholar
  44. Kensler CJ, Sugiura K, Young NF et al. (1941) Partial protection of rats by riboflavin with casein against liver cancer caused by dimethylaminoazobenzene. Science 93: 308–310PubMedGoogle Scholar
  45. Kershenobich D, Uribe M, Suarez GI et al. (1976) Treatment of cirrhosis with colchicine: a randomized trial. Gastroenterology 70: 986Google Scholar
  46. Kershenobich D, Uribe M, Suarez GI et al. (1979) Treatment of cirrhosis with colchicine: a double-blind randomized trial. Gastroenterology 77: 532–536PubMedGoogle Scholar
  47. Koch OR, Porta EA, Hartroft WS (1969) A new experimental approach in the study of chronic alcoholism. V. Super diet. Lab Invest 21: 298–303Google Scholar
  48. Korsten MA, Lieber CS (1979) Nutrition in the alcoholic. Med Clin North Am 63: 963–972PubMedGoogle Scholar
  49. Kramer K, Kuller L, Fisher R (1968) The increasing mortality attributed to cirrhosis and fatty liver in Baltimore (1957–1966). Ann Intern Med 69: 273–282PubMedGoogle Scholar
  50. Leevy CM (1962) Fatty liver: a study of 270 patients with biopsy proven fatty liver and a review of the literature. Medicine 41: 249–278PubMedGoogle Scholar
  51. Leevy CM (1967) Clinical diagnosis, evaluation and treatment of liver disease in alcoholics. Fed Proc 26: 1474–1481PubMedGoogle Scholar
  52. Leevy CM (1968) Cirrhosis in alcoholics. Med Clin North Am 52: 1445–1455PubMedGoogle Scholar
  53. Leevy CM (1970) Hard liquor and cirrhosis. In: Engle E, Larsson J (eds) Leevy CM, pp 283–285 ( Skandia international symposium )Google Scholar
  54. Leevy CM, George WS, Ziffer H et al. (1960) Pantothenic acid, fatty liver and alcoholism. J Clin Invest 39: 1005Google Scholar
  55. Leevy CM, Baker H, TenHove W et al. (1965) B-complex vitamins in liver disease of the alcoholic. Am J Clin Nutr 16: 339–346PubMedGoogle Scholar
  56. Leevy CM, Thompson A, Baker H (1970) Vitamins and liver injury. Am J Clin Nutr 23: 493–498PubMedGoogle Scholar
  57. Lelbach WK (1975) Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse. Ann NY Acad Sei 252: 85–105Google Scholar
  58. Lelbach WK (1976) Epidemiology of alcoholic liver disease. In: Popper H, Schaffner F (eds) Progress in liver disease, vol 5. Grune and Stratton, New York, pp 494–515Google Scholar
  59. Lesener HR, Bozymski EM, Fallon HF (1978) Treatment of alcoholic hepatitis with encephalopathy: comparison of prednisolone with caloric supplements. Gastroenterology 74: 169–173Google Scholar
  60. Levin DM, Baker AL, Riddell RH et al. (1979) Nonalcoholic liver disease: overlooked causes of liver injury in patients with heavy alcohol consumption. Am J Med 66: 429–434PubMedGoogle Scholar
  61. Lieber CS, Jones DP, Mendelson J, et al. (1963) Fatty liver, hyperlipemia and hyperuricemia produced by prolonged alcohol consumption despite adequate dietary intake. Trans Assoc Am Physicians 76: 289–301Google Scholar
  62. Lischner MW, Alexander JF, Galambos JT (1971) Natural history of alcohol. I. The acute disease. Am J Dig Dis 16: 481–494PubMedGoogle Scholar
  63. Lybecker LA, Mendenhall CL, Marshall LE et al. (1983) Response to hepatitis B vaccine (HBVac). Hepatology 3: 807Google Scholar
  64. Maddrey WC, Boitnott JK, Weber FL et al. (1975) Corticosteroid treatment of active alcoholic liver disease - a controlled trial. Gastroenterology 69: 843Google Scholar
  65. Maddrey WC, Boitnott JK, Bedine MS et al. (1978) Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 75: 193–199PubMedGoogle Scholar
  66. Marshall JB, Burnett DA, Zetterman RK et al. (1983) Clinical and biochemical course of alcoholic liver disease following sudden discontinuation of alcoholic consumption. Alcoholism 7: 312–315PubMedGoogle Scholar
  67. Mendenhall CL (1968) Anabolic steroid therapy as an adjunct to diet in alcoholic hepatic steatosis. Am J Dig Dis 13: 783–791PubMedGoogle Scholar
  68. Mendenhall CL (1974) Augmented release of hepatic triglycerides with anabolic steroids in patients with fatty liver. Am J Dig Dis 19: 122–126PubMedGoogle Scholar
  69. Mendenhall CL, Cooperative Study Group on Alcoholic Hepatitis (1981) Alcoholic hepatitis. Clin Gastroenterol 10: 417–441PubMedGoogle Scholar
  70. Mendenhall CL, Cooperative Study Group on Alcoholic Hepatitis (1983) Survival after steroid treatment for alcoholic hepatitis. Hepatology 3: 850Google Scholar
  71. Mendenhall CL, Goldberg SJ (1977) Risk factors and therapy in alcoholic hepatitis (AH). Gastroenterology 72: 1100Google Scholar
  72. Mendenhall CL, Anderson S, Weesner RE (1983) A clinical study of protein calorie malnutrition associated with alcoholic hepatitis. Am J MedGoogle Scholar
  73. Mezey E, Faillace LA (1971) Metabolic impairment and recovery time in acute ethanol intoxication. J Nerv Ment Dis 153: 445–452PubMedGoogle Scholar
  74. Mikkelsen WP, Turrill FL, Kern WH (1968) Acute hyalin necrosis of the liver: a surgical trap. Am J Surg 116: 266–272PubMedGoogle Scholar
  75. Miller LL, Whipple GH (1940) Chloroform liver injury increases as protein stores decrease. Am J Med Sci 199: 204–216Google Scholar
  76. Mitchell D, Wagner C, Stone WJ et al. (1976) Abnormal regulation of plasma pyridoxal 5’-phosphate in patients with liver disease. Gastroenterology 71: 1043–1049PubMedGoogle Scholar
  77. Nasrallah SM, Galambos JT (1980) Aminoacid therapy of alcoholic hepatitis. Lancet II: 1276–1277Google Scholar
  78. National Institute on Alcohol Abuse and Alcoholism (1978) Third special report to the US Congress on Alcohol and Health from the Secretary of Health, Education and Welfare. DHEW Pub. No. 79–832. Supt of Docs, US Govt Printing Office, Washington, DCGoogle Scholar
  79. Nelson RS, Doctor VM (1960) Hepatic and serum vitamin B12 content in liver disease. Gastroenterology 38: 188–193PubMedGoogle Scholar
  80. Nishino K, Itokawa Y (1977) Thiamin metabolism in vitamin B6 or vitamin B12 deficient rats. J Nutr 107: 775–782PubMedGoogle Scholar
  81. Nolan J (1965) Alcohol as a factor in the illness of university service patients. Am J Med Sci 249: 135–142PubMedGoogle Scholar
  82. Nomenclature, diagnostic criteria and diagnostic methodology for diseases of the liver and biliary tract (1976) Proceedings 22. Fogarty International Center. US Government Printing Office. Washington DC, pp 6–7Google Scholar
  83. Olmsted JB, Borisy GG (1973) Microtubules. Annu Rev Biochem 42: 507–540PubMedGoogle Scholar
  84. Orrego H, Israel Y (1979) Biochemical, morphological and clinical correlates of alcoholic liver disease. In: Thurman RG (ed) Alcohol and aldehyde metabolizing systems - IV. Plenum, New York, pp 497–508Google Scholar
  85. Orrego H, Kalant H, Israel Y et al. (1977) Effect of propylthiouracil in treatment of alcoholic liver disease. Gastroenterology 73: A39 /1237Google Scholar
  86. Orrego H, Kalant H, Israel Y et al. (1979) Effect of short term therapy with propylthiouracil in patients with alcoholic liver disease. Gastroenterology 76: 105–115PubMedGoogle Scholar
  87. Orrego H, Israel Y, Blendis LM (1981) Alcoholic liver disease: information in search of knowledge? Hepatology 1: 267–283PubMedGoogle Scholar
  88. Parker TH, Marshall JP, Roberts RK et al. (1979) Effect of acute alcohol ingestion on plasma pyridoxal 5’-phosphate. Am J Clin Nutr 32: 1246–1252PubMedGoogle Scholar
  89. Patek AJ (1979) Alcohol, malnutrition and alcoholic cirrhosis. Am J Clin Nutr 32: 1304–1312PubMedGoogle Scholar
  90. Patek AJ, Post J (1941) Treatment of cirrhosis of the liver by a nutritious diet and supplements rich in vitamin B complex. J Clin Invest 20: 481–505PubMedGoogle Scholar
  91. Patek AJ, Post J, Ratnoff OD et al. (1948) Dietary treatment of cirrhosis of the liver. Results in 124 patients observed during a 10 year period. JAMA 138: 543–549Google Scholar
  92. Patek AJ, Toth MG, Saunders GA et al. (1975) Alcohol and dietary factors in cirrhosis: an epidemiological study of 304 alcoholic patients. Arch Intern Med 135: 1053–1057PubMedGoogle Scholar
  93. Patek AJ, Bowry SC, Sabesin SM (1976) Minimal hepatic changes in rats fed alcohol and high casein diet. Arch Pathol Lab Med 100: 19–24PubMedGoogle Scholar
  94. Pell S, D’Alonzo CA (1968) The prevalence of chronic disease among problem drinkers. Arch Environ Health 16: 679–684PubMedGoogle Scholar
  95. Phillips GB (1983) Acute hepatic insufficiency of the chronic alcoholic — revisited. Am J Med 75: 1–3PubMedGoogle Scholar
  96. Phillips GB, Davidson CS (1954) Acute hepatic insufficiency of the chronic alcoholic: clinical and pathology study. Arch Intern Med 94: 585–604Google Scholar
  97. Phillips GH, Gabuzda GJ, Davidson CS (1952) Comparative effects of a purified and an adequate diet on the course of fatty cirrhosis in the alcoholic. J Clin Invest 31: 351–356PubMedGoogle Scholar
  98. Pirola RC, Lieber CS (1972) The energy cost of the metabolism of drugs including ethanol. Pharmacology 7: 185–196PubMedGoogle Scholar
  99. Popper H (1971) The problem of hepatitis. Am J Gastroenterol 55: 335–346PubMedGoogle Scholar
  100. Popper H, Davidson CS, Leevy CM et al. (1969) The social impact of liver disease. N Engl J Med 281: 1455 - 1458PubMedGoogle Scholar
  101. Porta EA, Koch OR, Gomez-Dumm CLA et al. (1968) Effects of diet protein on the liver of rats in experimental alcoholism. J Nutr 94: 437–446PubMedGoogle Scholar
  102. Porter HR, Simon FR, Pope CF et al. (1971) Corticosteroid therapy in severe alcoholic hepatitis: a double-blind drug trial. N Engl J Med 284: 1350–1355PubMedGoogle Scholar
  103. Powell WJ, Klatskin G (1968) Duration of survival in patients with Laennec’s cirrhosis. Influence of alcohol withdrawal and possible effects of recent changes in general management of the disease. Am J Med 44: 406–420PubMedGoogle Scholar
  104. Quadde F (1969) Glucocorticoid in liver diseases. Acta Med Scand [Suppl500] 186: 49–54Google Scholar
  105. Rankin JG (1976) The natural history and management of the patient with alcoholic liver disease. In: Fisher MM, Rankin JG (eds) Alcohol and the liver. Plenum, New York, pp 365–381Google Scholar
  106. Rankin JGD, Orrego-Matte H, Deschenes J et al. (1978) Alcoholic liver disease: the problem of diagnosis. Alcoholism 4: 327–338Google Scholar
  107. Raskin NH, Sligar KP, Steinberg RH (1976) A pathophysiologic role for alcohol dehydrogenase: is retinol its “natural” substrate? Ann NY Acad Sci 273: 317–327PubMedGoogle Scholar
  108. Resnick RH, Boitnott J, Iber FT et al. (1974) Preliminary observations of δ-penicillamine therapy in acute alcoholic liver disease. Digestion 11: 257–265PubMedGoogle Scholar
  109. Reynolds TB, Redeker AG, Kuzma OT (1965) Role of alcohol in pathogenesis of alcoholic cirrhosis. In: Mclntyre N, Sherlock S (eds) Therapeutic agents and the liver. Blackwell, Oxford, pp 131–142Google Scholar
  110. Rhodes RJ, Hames GH, Campbell MD (1969) The problem of alcoholism among hospitalized tuberculous patients. Am Rev Respir Dis 99: 440–442PubMedGoogle Scholar
  111. Rojkind M, Uribe M, Kershenobich D (1973) Colchicine and the treatment of liver cirrhosis (letter). Lancet 1: 38–39Google Scholar
  112. Romero JJ, Tamura T, Halsted CH (1981) Intestinal absorption of (3H) folic acid in the chronic alcoholic monkey. Gastroenterology 80: 99–102PubMedGoogle Scholar
  113. Rosen F, Roberts NR, Nichol CA (1959) Glucocorticosteroids and transaminase activity. I. Increased activity of glutamic-pyruvic transaminase in four conditions associated with gluconeogenesis. J Biol Chem 243: 476–480Google Scholar
  114. Rossouw JE, Labadarios D, McConnell JB et al. (1977) Plasma pyridoxal phosphate levels in fluminant hepatic failure and the effects of parenteral supplementation. Scand J Gastroenterol 12: 123–127PubMedGoogle Scholar
  115. Russell RM (1980) Vitamin A and zinc metabolism in alcoholism. Am J Clin Nutr 33: 2741–2749PubMedGoogle Scholar
  116. Rydberg U, Skerfuing S (1977) Toxicity of ethanol. A tentative risk evaluation. In: Gross EM (ed) Alcohol intoxication and withdrawal. Plenum, New York, pp 403–418Google Scholar
  117. Sabesin SM, Hawkins HL, Bertram PD et al. (1978) Alcoholic hepatitis. Gastroenterology 74: 276–286PubMedGoogle Scholar
  118. Schaffner F, Popper H (1970) Alcoholic hepatitis in the spectrum of ethanol-induced liver injury. Scand J Gastroenterol 5: 69–78Google Scholar
  119. Smith JC, McDaniel EM, Fan FF et al. (1973) Zinc: a trace element essential in vitamin A metabolism. Science 181: 954–955PubMedGoogle Scholar
  120. Smith MI (1939) The influence of diet on the chronic toxicity of selenium. US Public Health Rep 54: 1441–1453Google Scholar
  121. Sorrell MF, Baker H, Barak AJ (1974) Release by ethanol of vitamins into rat liver perfusates. Am J Clin Nutr 27: 743–745PubMedGoogle Scholar
  122. Spain DM (1945) Portal cirrhosis of the liver: review of 250 necropsies with reference to sex differences. Am J Clin Pathol 15: 215–218Google Scholar
  123. Spies TD, Dewolf HF (1933) Observations on the etiological relationship of severe alcoholism to pellagra. Am J Med Sci 186: 521–525Google Scholar
  124. Stanko RT, Mendenlow H, Shinozuka H et al. (1978) Prevention of alcohol-induced fatty liver by natural metabolites and riboflavin. J Lab Clin Med 91: 228–235PubMedGoogle Scholar
  125. Strauss MB (1953) The etiology of “alcoholic” polyneuritis. Am J Med Sci 189: 378–382Google Scholar
  126. Summerskill WHJ, Wolfe SJ, Davidson CS (1957) Response to alcohol in chronic alcoholics with liver disease. Clinical, pathological and metabolic changes. Lancet 1: 335–340Google Scholar
  127. Tamburro C, Leevy CM (1967) Protein clotting factor synthesis in liver disease. Gastroenterology 52: 325Google Scholar
  128. Tashiro M, Lipscomb WR (1963) Mortality experience of alcoholics. QJ Stud Alcohol 24: 203–212Google Scholar
  129. Theodossi A, Eddieston ALWF, Williams R (1982) Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis. Gut 23: 75–79PubMedGoogle Scholar
  130. Thomson AD, Baker H, Leevy CM (1970) Patterns of 35S-thiamine hydrochloride absorption in the malnourished alcoholic patient. J Lab Clin Med 76: 34–45PubMedGoogle Scholar
  131. Tomasulo PA, Kater MH, Iber FL (1968) Impairment of thiamine absorption in alcoholism. Am J Clin Nutr 21: 1341–1344PubMedGoogle Scholar
  132. US Bureau of the Census, Dept of Commerce (1975) Statistical abstract of the United States - 1975. US Govt Printing Office, Washington, p 65Google Scholar
  133. Veitch RL, Lumeng L, Li T (1975) Vitamin B6 metabolism in chronic alcohol abuse: the effect of ethanol oxidation on hepatic pyridoxal 5’-phosphate metabolism. J Clin Invest 55: 1026–1032Google Scholar
  134. Videla L, Bernstein J, Israel Y (1973) Metabolic alterations produced in the liver by chronic ethanol administration. Increased oxidative capacity. Biochem J 134: 507–514Google Scholar
  135. Volwiler W, Jones CM, Mallory TB (1948) Criteria for the measurement of results of treatment in fatty cirrhosis. Gastroenterology 11: 164–182PubMedGoogle Scholar
  136. VonGlahn WC, Flinn FB (1939) The effect of yeast on the incidence of cirrhosis produced by lead arsenate. Am J Pathol 15: 771–789Google Scholar
  137. Weesner RE, Mendenhall CL, Giannella RA et al. (1983) A comparison of serum elastase I (E), trypsin (T) and pancreatic isoamylase (PI) in patients with acute pancreatitis ( AP) and chronic alcoholism. Dig Dis Sci 28: 952Google Scholar
  138. Youmans JB (1951) Deficiencies of the water-soluble vitamins. In: Handbook of nutrition. Blakiston, New York, pp 533–576Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1985

Authors and Affiliations

  • C. L. Mendenhall
    • 1
  • VA Cooperative Study on Alcoholic Hepatitis
    • 1
  1. 1.Veterans Administration Medical CenterCincinnatiUSA

Personalised recommendations